Plunkett Research Online: AVEO Pharmaceuticals Inc

AVEO PHARMACEUTICALS INC (AVEO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AVEO Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The firm develops and commercializes its product candidates in North America, while leveraging partnerships to support development and commercialization in other geographics. With the U.S. Food and Drug Administration (FD.....



AVEO Pharmaceuticals Inc
Ticker: AVEO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 857-400-0101
Fax:
Address: One Broadway
14th Floor
Cambridge, MA 02142 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs (Pharmaceuticals), Discovery & Manufacturing
Biopharmaceuticals
Drug Development
Drug Commercialization
Oncology
Contacts Description

Michael Bailey CEO/Director/President
Matthew Dallas CFO/Chief Accounting Officer
See More
AVEO Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The firm develops and commercializes its product candidates in North America, while leveraging partnerships to support development and commercialization in other geographics. With the U.S. Food and Drug Administration (FD.....See More See More

Auditor: EY
Legal Advisor: Wilmer Cutler Pickering Hale and Dorr LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
FOTIVDA
Tivozanib
AV-380
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: